申请人:Briggner Lars-Erik
公开号:US20090221640A1
公开(公告)日:2009-09-03
Novel crystal modifications of (5S)-5-[4-(5-chloro-pyridin-2-yloxy)-piperidine-1-sulfonylmethyl]-5-methyl-imidazolidine-2,4-dione are disclosed together with processes for preparing such modifications, pharmaceutical compositions comprising such a modification, and the use of such a modification in therapy.
本发明公开了(5S)-5-[4-(5-氯吡啶-2-氧基)-哌啶-1-磺酰甲基]-5-甲基咪唑烷-2,4-二酮的新颖晶体修饰,以及制备该修饰的过程、包含该修饰的药物组合物,以及在治疗中使用该修饰的方法。